Croda International Plc (LON:CRDA)
London flag London · Delayed Price · Currency is GBP · Price in GBX
3,258.00
-27.00 (-0.82%)
Aug 14, 2026, 4:35 PM GMT

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Europe, Middle East & Africa Revenue
700.10M685.10M626.50M
North America Revenue
393.10M401.10M393.00M
Latin America Revenue
193.40M186.70M180.50M
Asia Revenue
437.50M426.50M428.10M
Revenue (Total)
1.72B1.70B1.63B

Revenue

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Consumer Care Revenue
1.00B972.70M920.00M
Life Science Revenue
528.50M532.20M504.30M
Industrial Specialties Revenue
191.00M194.50M203.80M
Revenue (Total)
1.72B1.70B1.63B

Adjusted EBIT

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Consumer Care Adjusted Operating Profit
182.20M169.80M160.20M
Life Science Adjusted Operating Profit
114.10M116.50M104.00M
Industrial Specialties Adjusted Operating Profit
7.90M9.00M15.50M
Operating Income (Total)
131.20M110.10M227.50M

Key Performance Indicators

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Sales Growth due to Price/Mix
-3.00%-5.50%
Sales Growth due to Volume
9.60%6.90%